1
Clinical Trials associated with 3BP-4961Fibroblast Activation protein imaging research SPECT/CT (FIRST-NT): Assessing the safety and tolerability of 99mTc-3BP-4961 SPECT/CT in participants with clinical suspicion of active cancer
Start Date01 Jan 2025 |
Sponsor / Collaborator- |
100 Clinical Results associated with 3BP-4961
100 Translational Medicine associated with 3BP-4961
100 Patents (Medical) associated with 3BP-4961
100 Deals associated with 3BP-4961